Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
immunicum
-
search results
If you're not happy with the results, please do another search
Mendus in strong position for clinical progress
1 September, 2022
Immunicum changes name to Mendus
1 July, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
Immunicum delivers positive phase II data in AML
19 May, 2022
Immunicum to present data for potential AML treatment
6 May, 2022
Immunicum participates in new cancer research consortium
21 April, 2022
Cancer vaccines – a new frontier in immuno-oncology
7 April, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
Immunicum’s strategy for fighting tumour recurrence
23 March, 2022
Elicera well-positioned to thrive in 2022
20 January, 2022
Immunicum can look back on a transformative 2021
11 January, 2022
Immunicum finalises phase I ILIAD trial
8 December, 2021
Immunicum publishes DCP-001 data
26 November, 2021
Immunicum’s vision for the cancer therapy landscape
3 November, 2021
Eight CEOs on their expectations at BIO-Europe
25 October, 2021
BioStock Studio: Immunicum’s CEO on the company’s new therapeutic focus
13 September, 2021
Immunicum addresses essential challenges in cancer therapy
7 September, 2021
Positive preclinical results for Immunicum
6 July, 2021
Immunicum attacks cancer with an immune activation “bomb”
6 July, 2021
2019 marked steady progress for Immunicum’s ilixadencel
6 July, 2021
Immunicum presents positive MERECA Phase II data
6 July, 2021
Immunicum’s advancements with ilixadencel highlighted in year-end report
6 July, 2021
Annual report highlights Immunicum’s competitive advantages
5 July, 2021
Immunicum’s ilixadencel granted regenerative medicine advanced therapy designation from FDA
5 July, 2021
Immunicum’s immuno-oncology platform shares the spotlight at Cancer Progress conference
5 July, 2021
Immunicum gears up for second half of 2020
4 July, 2021
Immunicum announces MERECA trial update
4 July, 2021
New CEO brings deal-making experience to Immunicum
4 July, 2021
Immunicum updates clinical development strategy
3 July, 2021
BioStock Studio: Immunicum and DCprime enter immuno-oncology merger
3 July, 2021
Elicera Therapeutics takes immuno-oncology to the next level
2 March, 2021
Watch company presentations & panels from the BioStock Life Science Summit...
29 November, 2020
Strong line-up at the BioStock Life Science Summit 2020
16 November, 2020
Ultimovacs on track to develop universal cancer vaccine
24 September, 2020
BLSS 2019 videos: both bio- and medtech on display in third...
31 October, 2019